PEAK6 Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

PEAK6 Investments’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,900	Closed	-$1.65M	–	3596
2024 Q1	$1.65M	Sell	18,900 -2,500	-12%	-$224K	﹤0.01%	1583
2023 Q4	$2.06M	Buy	+21,400	New	+$1.89M	0.01%	1494
2023 Q3	–	Sell	-12,800	Closed	-$1.11M	–	4071
2023 Q2	$1.11M	Sell	12,800 -110,100	-90%	-$10.4M	0.01%	1642
2023 Q1	$12M	Buy	+122,900	New	+$12.7M	0.06%	323
2022 Q4	–	Sell	-18,600	Closed	-$1.58M	–	4459
2022 Q3	$1.58M	Buy	18,600 +5,800	+45%	+$516K	0.01%	1776
2022 Q2	$1.11M	Buy	+12,800	New	+$1.02M	﹤0.01%	2976
2021 Q3	–	Sell	-37,900	Closed	-$3.16M	–	5180
2021 Q2	$3.16M	Buy	37,900 +9,000	+31%	+$713K	0.01%	1468
2021 Q1	$2.18M	Sell	28,900 -23,600	-45%	-$1.93M	0.01%	1793
2020 Q4	$4.6M	Sell	52,500 -12,500	-19%	-$991K	0.01%	1120
2020 Q3	$4.95M	Buy	65,000 +45,000	+225%	+$4.55M	0.01%	957
2020 Q2	$2.47M	Buy	+20,000	New	+$1.99M	0.01%	1312
2019 Q4	–	Sell	-2,200	Closed	-$148K	–	3407
2019 Q3	$148K	Hold	2,200	–	–	﹤0.01%	3059
2019 Q2	$188K	Sell	2,200 -26,300	-92%	-$2.25M	﹤0.01%	2892
2019 Q1	$2.53M	Buy	+28,500	New	+$2.64M	0.01%	1140
2018 Q4	–	Sell	-1,800	Closed	-$175K	–	4026
2018 Q3	$175K	Buy	+1,800	New	+$180K	﹤0.01%	3297

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

PEAK6 Investments's BMRN Position: Q3 2024 in Review

PEAK6 Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 49% in Q3 2024, selling an estimated $485K and leaving 6,047 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

PEAK6 Investments first reported a position in BMRN in Q3 2018 and has held it in 17 quarters since. The position peaked at $6M in Q3 2018. 554 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

PEAK6 Investments held 6,047 shares of BioMarin Pharmaceuticals worth $425K as of Q3 2024.
PEAK6 Investments sold 5,800 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $485K.
BioMarin Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2410 holding.
PEAK6 Investments first reported a position in BioMarin Pharmaceuticals in Q3 2018 and has held it in 17 quarters since.
PEAK6 Investments's BioMarin Pharmaceuticals position peaked at $6M in Q3 2018.
554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.